Company / Total Assets
Outlook Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$18.6M
FY2025
5-year range
$17.1M / $22.3M
FY2021-FY2025
Trend
-5.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 6 years, ranging from $17M in FY2019 to $24M in FY2016.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of -1.2%.
Improved from $17M to $19M over the past 6 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -1.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.2%, indicating a declining trend.
- In FY2025, total assets decreased 5.8% year-over-year.
- Peak total assets was recorded in FY2016.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.6M | -5.8% |
| FY2020 | $19.7M | +15.2% |
| FY2019 | $17.1M | -23.1% |
| FY2018 | $22.3M | +7.5% |
| FY2017 | $20.7M | -12.5% |
| FY2016 | $23.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026